Puma Biotechnology Inc
NASDAQ:PBYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
|
S
|
Sunwin Stevia International Inc
OTC:SUWN
|
CN |
|
BYC Co Ltd
KRX:001460
|
KR |
|
Z
|
Zhejiang Haisen Pharmaceutical Co Ltd
SZSE:001367
|
CN |
|
CM Hospitalar SA
BOVESPA:VVEO3
|
BR |
|
Porto Seguro SA
BOVESPA:PSSA3
|
BR |
|
L
|
Live Nation Entertainment Inc
XETRA:3LN
|
US |
|
S
|
Sleeping Giant Capital Corp
XTSX:SSX.P
|
CA |
|
Patel Engineering Ltd
NSE:PATELENG
|
IN |
|
Mangalam Organics Ltd
NSE:MANORG
|
IN |
|
Victoria Gold Corp
TSX:VGCX
|
CA |
|
Cardiff Property PLC
LSE:CDFF
|
UK |
|
R
|
Recreate ASA
OSE:RCR
|
NO |
|
Enerside Energy SA
MAD:ENRS
|
ES |
|
Al Rajhi Banking & Investment Corporation SJSC
SAU:1120
|
SA |
|
C
|
China Vered Financial Holding Corporation Ltd
HKEX:245
|
HK |
|
M
|
MIX Telematics Ltd
JSE:MIX
|
ZA |
|
S
|
Speciality Restaurants Ltd
NSE:SPECIALITY
|
IN |
|
K
|
Know Labs Inc
AMEX:KNW
|
US |
Bankruptcy Probability
Puma Biotechnology Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Puma Biotechnology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
377.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Puma Biotechnology Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Puma Biotechnology Inc has no debt.
You can find a full breakdown on its Balance Sheet.
